Haleon News

6-K: Voting Results of Shareholders Meeting

13:08 ET

6-K: Issuance of a Basic Prospectus

May 7 07:34 ET

6-K: 2024 Q1 Trading Statement

May 1 10:59 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 1 08:29 ET

Haleon | 6-K: Haleon Appoints Dawn Allen as Corporate CFO

Apr 24 06:13 ET

Haleon | 6-K: Notice Of Annual General Meeting

Apr 12 07:51 ET

Haleon | 6-K: Notification And Public Disclosure Of Transactions By Persons Discharging Managerial Responsibilities And Their Closely Associated Persons

Apr 3 07:27 ET

Haleon | 6-K: Total Voting Rights and Capital

Apr 2 09:24 ET

Haleon | 6-K: Disclosure of Holding(S) of Voting Rights in Company

Mar 22 08:07 ET

Haleon | 6-K: Haleon Announces Cancellation of Repurchased Common Shares

Mar 21 13:51 ET

Haleon | 6-K: Buyback Of £315m Of Pfizer Ordinary Shares In Secondary Global Offering

Mar 21 13:26 ET

Haleon | 6-K: Prospectus Supplement of Haleon

Mar 20 09:02 ET

Haleon | 6-K: Haleon Plc To Expand Repurchase Of Ordinary Shares From Pfizer In Secondary Global Offering Pricing

Mar 19 06:06 ET

Haleon | 6-K: Prospectus Supplement of Haleon

Mar 18 11:00 ET

Haleon | 6-K: Haleon plc: Proposed Secondary Global Offering by Pfizer Inc. in Haleon plc and Proposed Share Buyback

Mar 18 10:24 ET

Haleon | 6-K: Entered Into A Share Repurchase Agreement

Mar 18 06:09 ET

Haleon | 6-K: Consent of Independent Registered Public Accounting Firm

Mar 18 06:09 ET

Haleon | 6-K: Haleon Releases 2023 Annual Report and Form 20-F

Mar 15 13:06 ET

Haleon | 6-K: 2023 Annual Report and Form 20-F

Mar 15 11:20 ET

Haleon | 6-K: Notification And Public Disclosure Of Transactions By Persons Discharging Managerial Responsibilities And Their Closely Associated Persons

Mar 14 13:39 ET